What a pittance in relation to the billions that Purdue made by lying about the addictive qualities of a drug that should have only been used for palliative patients.  They have effectively transferred billions of costs onto an already stretched health care system in both Canada and the U.S.  I first heard oxycondin in the mid 2000s working in disability/rehab in health care.  The spike in addicted employees was noticeable and the type of addict was different than the usual troubled person with a family history of addiction.  These employees were often prescribed this drug for conditions where an aspirin would have been suitable but the GPs had been told it was a safe, non-addictive drug.   One colleague will an unused prescription decided to try one to see what the fuss was about.  He said the feeling of euphoria was so overwhelming that if he didn't know the face of addiction well, he'd have succumbed.  He returned the rest to the pharmacy for disposal.